ZA965361B - Recombinant mistletoe lectin (rML). - Google Patents

Recombinant mistletoe lectin (rML).

Info

Publication number
ZA965361B
ZA965361B ZA9605361A ZA965361A ZA965361B ZA 965361 B ZA965361 B ZA 965361B ZA 9605361 A ZA9605361 A ZA 9605361A ZA 965361 A ZA965361 A ZA 965361A ZA 965361 B ZA965361 B ZA 965361B
Authority
ZA
South Africa
Prior art keywords
rml
mistletoe lectin
recombinant mistletoe
recombinant
lectin
Prior art date
Application number
ZA9605361A
Other languages
English (en)
Inventor
Hans Lentzen
Juergen Eck
Axel Baur
Holger Zinke
Original Assignee
Madaus A G Koeln
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Madaus A G Koeln filed Critical Madaus A G Koeln
Publication of ZA965361B publication Critical patent/ZA965361B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/415—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from plants
    • C07K14/42—Lectins, e.g. concanavalin, phytohaemagglutinin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/68—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment
    • A61K47/6801—Drug-antibody or immunoglobulin conjugates defined by the pharmacologically or therapeutically active agent
    • A61K47/6803—Drugs conjugated to an antibody or immunoglobulin, e.g. cisplatin-antibody conjugates
    • A61K47/6811—Drugs conjugated to an antibody or immunoglobulin, e.g. cisplatin-antibody conjugates the drug being a protein or peptide, e.g. transferrin or bleomycin
    • A61K47/6817—Toxins
    • A61K47/6819—Plant toxins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Botany (AREA)
  • Biophysics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Wood Science & Technology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Virology (AREA)
  • Analytical Chemistry (AREA)
  • Plant Pathology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
ZA9605361A 1995-06-26 1996-06-25 Recombinant mistletoe lectin (rML). ZA965361B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP95109949A EP0751221B1 (de) 1995-06-26 1995-06-26 Rekombinantes Mistellektin (rML)

Publications (1)

Publication Number Publication Date
ZA965361B true ZA965361B (en) 1997-08-27

Family

ID=8219389

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA9605361A ZA965361B (en) 1995-06-26 1996-06-25 Recombinant mistletoe lectin (rML).

Country Status (21)

Country Link
US (1) US6271368B1 (hu)
EP (3) EP0751221B1 (hu)
JP (2) JP3291548B2 (hu)
KR (1) KR100292918B1 (hu)
CN (1) CN1160457C (hu)
AR (1) AR003961A1 (hu)
AT (1) ATE170922T1 (hu)
AU (1) AU719297B2 (hu)
BR (1) BR9609223A (hu)
CA (1) CA2225924C (hu)
CZ (1) CZ292689B6 (hu)
DE (1) DE59503524D1 (hu)
DK (1) DK0751221T3 (hu)
ES (1) ES2124470T3 (hu)
HU (1) HU225738B1 (hu)
NO (1) NO327165B1 (hu)
PL (1) PL193281B1 (hu)
RU (1) RU2241750C2 (hu)
SK (1) SK173197A3 (hu)
WO (1) WO1997001636A2 (hu)
ZA (1) ZA965361B (hu)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU6092498A (en) * 1997-01-02 1998-07-31 B.R.A.I.N. Biotechnology Research And Information Network Gmbh Recombinant fusion proteins based on ribosome-inactivating proteins of european mistletoe (viscum album)
CN1104438C (zh) * 1997-06-02 2003-04-02 山东医科大学附属医院 槲寄生提取物及其用途
DE19804210A1 (de) * 1998-02-03 1999-08-12 Biosyn Arzneimittel Gmbh Rekombinante Mistellektine
KR20010011330A (ko) * 1999-07-27 2001-02-15 김종배 한국산 겨우살이 추출물과 이로부터 분리한 단백질 및 상기 단백질에서 분리한 렉틴
DE10044027A1 (de) * 2000-09-06 2002-03-14 Viscum Ag Rekombinant erzeugtes Mistellektin (ML III)
NZ526202A (en) * 2000-11-14 2005-08-26 Ian Pryme Orally ingestible preparation of mistletoe lectins, ML-I, ML-II and ML-III and methods fro treating cancer and autoimmune diseases
ATE361664T1 (de) 2001-07-09 2007-06-15 Univ Copenhagen Verfahren und ableger für die massenvermehrung von pflanzenparasiten
DE10149030A1 (de) * 2001-10-05 2003-04-10 Viscum Ag Stabile galenische gefriergetrocknete Arzneimittelzubereitung von rViscumin
JP4681226B2 (ja) * 2001-12-21 2011-05-11 ビスカム・アーゲー ヤドリギレクチンに対する個体の応答性を判定する方法
DE102011003478A1 (de) 2011-02-01 2012-08-02 Cytavis Biopharma Gmbh Antivirales Mittel enthaltend rekombinante Mistellektine
EP2508195A1 (de) * 2011-04-06 2012-10-10 Cytavis BioPharma GmbH Arzneimittel enthaltend rekombinante Mistellektine zur Behandlung des malignen Melanoms
DK2723374T3 (da) * 2011-06-27 2017-11-20 Melema Pharma Gmbh Rekombinant mistelten-lektin og dettes anvendelse som adjuvans
US9616114B1 (en) 2014-09-18 2017-04-11 David Gordon Bermudes Modified bacteria having improved pharmacokinetics and tumor colonization enhancing antitumor activity
EP3205348A1 (de) * 2016-02-15 2017-08-16 Melema Pharma GmbH Arzneimittel enthaltend rekombinante mistellektine zur behandlung von hirntumoren
CN106166223A (zh) * 2016-09-17 2016-11-30 四川易创生物科技有限公司 一种治疗肺肾阴亏、潮热盗汗的中药组合物及其制备方法
US11180535B1 (en) 2016-12-07 2021-11-23 David Gordon Bermudes Saccharide binding, tumor penetration, and cytotoxic antitumor chimeric peptides from therapeutic bacteria
US11129906B1 (en) 2016-12-07 2021-09-28 David Gordon Bermudes Chimeric protein toxins for expression by therapeutic bacteria
CN115025207B (zh) * 2022-06-23 2023-02-07 黑龙江中医药大学 一种用于治疗类风湿性关节炎的药物及其制备方法
CN117924453A (zh) * 2024-03-19 2024-04-26 广东现代汉方科技有限公司 一种甘露糖特异性凝集素重组植物蛋白的制备方法及应用

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6127532A (en) * 1989-09-12 2000-10-03 Board Of Trustees Operating Michigan State University Lectin cDNA and transgenic plants derived therefrom
US5407454A (en) * 1989-11-07 1995-04-18 Pioneer Hi-Bred International, Inc. Larvicidal lectins and plant insect resistance based thereon
DE4221836A1 (de) 1992-07-03 1994-01-05 Gabius Hans Joachim Prof Dr Das biochemisch aufgereinigte Mistel-Lektin (ML-1) als therapeutisch anwendbarer Immunmodulator
DE4341476A1 (de) * 1993-12-02 1995-06-08 Uwe Dr Pfueller Mittel zur Untersuchung und Beeinflussung zellulärer Veränderungen auf Lektinbasis

Also Published As

Publication number Publication date
SK173197A3 (en) 1999-01-11
NO976058D0 (no) 1997-12-23
HUP9900316A3 (en) 2002-07-29
DK0751221T3 (da) 1999-06-07
MX9710522A (es) 1998-08-30
EP0835312A2 (de) 1998-04-15
RU2241750C2 (ru) 2004-12-10
CA2225924C (en) 2008-10-28
CN1192240A (zh) 1998-09-02
EP0884388A1 (de) 1998-12-16
JP3291548B2 (ja) 2002-06-10
WO1997001636A3 (de) 1997-03-27
NO976058L (no) 1998-02-03
BR9609223A (pt) 1999-05-11
JP2002300890A (ja) 2002-10-15
DE59503524D1 (de) 1998-10-15
JPH10508206A (ja) 1998-08-18
PL324209A1 (en) 1998-05-11
CA2225924A1 (en) 1997-01-16
NO327165B1 (no) 2009-05-04
HU225738B1 (en) 2007-07-30
CN1160457C (zh) 2004-08-04
PL193281B1 (pl) 2007-01-31
CZ404997A3 (cs) 1998-06-17
WO1997001636A2 (de) 1997-01-16
CZ292689B6 (cs) 2003-11-12
ES2124470T3 (es) 1999-02-01
AU719297B2 (en) 2000-05-04
EP0751221A1 (de) 1997-01-02
KR100292918B1 (ko) 2001-06-15
ATE170922T1 (de) 1998-09-15
KR19990028570A (ko) 1999-04-15
AU6416396A (en) 1997-01-30
US6271368B1 (en) 2001-08-07
AR003961A1 (es) 1998-09-30
HUP9900316A2 (hu) 1999-05-28
EP0751221B1 (de) 1998-09-09

Similar Documents

Publication Publication Date Title
ZA965361B (en) Recombinant mistletoe lectin (rML).
ZA9610191B (en) Pulmonary interface system.
EP0627232A3 (de) Steckverbindung.
ZA964468B (en) Triazolylmethyl-cyclopentanols.
EP0650063A3 (en) Connection device.
ZA961955B (en) Indazolecarboxamides.
IL119897A0 (en) Projecting images
EP0623913A3 (en) Electro-acoustic transducer.
DE69610844D1 (en) Hydroformylierungsverfahren.
IL117907A0 (en) Truncated IGF-I
EP0676855A3 (en) Electronic system discriminating power supply and with power supply adaptation.
EP0663607A3 (en) Camera.
GB9515538D0 (en) C-clamp
ZA966399B (en) Endothelin-receptor-antagonists.
GB9401350D0 (en) Diaphragm expansion tank
EP0643172A3 (de) Brücke.
ZA963184B (en) Coupling means.
ZA966933B (en) Endothelin-receptor-antagonists.
ZA967314B (en) Carbamoylcarboxamides.
HK1014964A1 (en) Somatostatin peptides.
GB9513699D0 (en) C-clamp
ZA967038B (en) Pipe connection.
GB9323965D0 (en) Scanning through technique
GB9800578D0 (en) Videoconferencing
EP0672680A4 (en) NEW PEPTID.